Current treatment standards for primary ovarian cancer
Current treatment standards for primary ovarian cancer
Evolving medical treatment in advanced/recurrent endometrial cancer
Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS
ITACA NSCLC study: Final results
Renal liposarcoma: Case report and review of systemic treatment
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC
ASCO GU 2021: Renal cancer roundup
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
WCLC 2020 overview
Emergence of PARP inhibitors in prostate cancer